Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 1 / 2 Trials for Cyclosporine (DB00091)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01650545Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant RecipientsTreatment